What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 3 minute read Pharma Industry News ExeGi Pharma’s EXE-346 receives FDA orphan drug designation for pouchitis treatment ExeGi Pharma, a biotechnology company headquartered in Rockville, Maryland, has announced that its live biotherapeutic product (LBP), EXE-346,… bypharmanewsdailyNovember 15, 2020
